These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 35659923)

  • 1. Immunomodulatory properties of mesenchymal stromal/stem cells: The link with metabolism.
    Li H; Dai H; Li J
    J Adv Res; 2023 Mar; 45():15-29. PubMed ID: 35659923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-conditioning mesenchymal stromal cell spheroids for immunomodulatory paracrine factor secretion.
    Zimmermann JA; McDevitt TC
    Cytotherapy; 2014 Mar; 16(3):331-45. PubMed ID: 24219905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of inflammatory environment on equine bone marrow derived mesenchymal stem cells immunogenicity and immunomodulatory properties.
    Barrachina L; Remacha AR; Romero A; Vázquez FJ; Albareda J; Prades M; Ranera B; Zaragoza P; Martín-Burriel I; Rodellar C
    Vet Immunol Immunopathol; 2016 Mar; 171():57-65. PubMed ID: 26964718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced Immunosuppression of T Cells by Sustained Presentation of Bioactive Interferon-γ Within Three-Dimensional Mesenchymal Stem Cell Constructs.
    Zimmermann JA; Hettiaratchi MH; McDevitt TC
    Stem Cells Transl Med; 2017 Jan; 6(1):223-237. PubMed ID: 28170190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory-compliant conditions during cell product manufacturing enhance in vitro immunomodulatory properties of infrapatellar fat pad-derived mesenchymal stem/stromal cells.
    Kouroupis D; Bowles AC; Greif DN; Leñero C; Best TM; Kaplan LD; Correa D
    Cytotherapy; 2020 Nov; 22(11):677-689. PubMed ID: 32723596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microenvironmental cues enhance mesenchymal stem cell-mediated immunomodulation and regulatory T-cell expansion.
    Kadle RL; Abdou SA; Villarreal-Ponce AP; Soares MA; Sultan DL; David JA; Massie J; Rifkin WJ; Rabbani P; Ceradini DJ
    PLoS One; 2018; 13(3):e0193178. PubMed ID: 29513756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Musculoskeletal Progenitor/Stromal Cell-Derived Mitochondria Modulate Cell Differentiation and Therapeutical Function.
    Jorgensen C; Khoury M
    Front Immunol; 2021; 12():606781. PubMed ID: 33763061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a human umbilical cord-derived mesenchymal stromal cell-based advanced therapy medicinal product to treat immune and/or inflammatory diseases.
    Mebarki M; Iglicki N; Marigny C; Abadie C; Nicolet C; Churlaud G; Maheux C; Boucher H; Monsel A; Menasché P; Larghero J; Faivre L; Cras A
    Stem Cell Res Ther; 2021 Nov; 12(1):571. PubMed ID: 34774107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients.
    Kwon MS; Noh MY; Oh KW; Cho KA; Kang BY; Kim KS; Kim YS; Kim SH
    J Neurochem; 2014 Oct; 131(2):206-18. PubMed ID: 24995608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Immunomodulatory Properties of the Human Amnion-Derived Mesenchymal Stromal/Stem Cells Are Induced by INF-γ Produced by Activated Lymphomonocytes and Are Mediated by Cell-To-Cell Contact and Soluble Factors.
    Bulati M; Miceli V; Gallo A; Amico G; Carcione C; Pampalone M; Conaldi PG
    Front Immunol; 2020; 11():54. PubMed ID: 32117234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunomodulation-immunogenicity balance of equine Mesenchymal Stem Cells (MSCs) is differentially affected by the immune cell response depending on inflammatory licensing and major histocompatibility complex (MHC) compatibility.
    Cequier A; Vázquez FJ; Romero A; Vitoria A; Bernad E; García-Martínez M; Gascón I; Barrachina L; Rodellar C
    Front Vet Sci; 2022; 9():957153. PubMed ID: 36337202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulatory Mechanisms of Mesenchymal Stem Cells and Their Potential Clinical Applications.
    Huang Y; Wu Q; Tam PKH
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stromal cell based therapies for the treatment of immune disorders: recent milestones and future challenges.
    Gonzalez-Pujana A; Igartua M; Santos-Vizcaino E; Hernandez RM
    Expert Opin Drug Deliv; 2020 Feb; 17(2):189-200. PubMed ID: 31918562
    [No Abstract]   [Full Text] [Related]  

  • 14. Dose and duration of interferon γ pre-licensing interact with donor characteristics to influence the expression and function of indoleamine-2,3-dioxygenase in mesenchymal stromal cells.
    Boyt DT; Boland LK; Burand AJ; Brown AJ; Ankrum JA
    J R Soc Interface; 2020 Jun; 17(167):20190815. PubMed ID: 32546114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Key Metabolic Pathways in MSC-Mediated Immunomodulation: Implications for the Prophylaxis and Treatment of Graft Versus Host Disease.
    Burnham AJ; Foppiani EM; Horwitz EM
    Front Immunol; 2020; 11():609277. PubMed ID: 33365034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IDO and CD40 May Be Key Molecules for Immunomodulatory Capacity of the Primed Tonsil-Derived Mesenchymal Stem Cells.
    Lee HJ; Jung H; Kim DK
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071285
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of pro-inflammatory cytokines on immunophenotype, differentiation capacity and immunomodulatory functions of human mesenchymal stem cells.
    Pourgholaminejad A; Aghdami N; Baharvand H; Moazzeni SM
    Cytokine; 2016 Sep; 85():51-60. PubMed ID: 27288632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal Stem Cell Immunomodulation: Mechanisms and Therapeutic Potential.
    Song N; Scholtemeijer M; Shah K
    Trends Pharmacol Sci; 2020 Sep; 41(9):653-664. PubMed ID: 32709406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulation by Mesenchymal Stem Cells (MSCs): Mechanisms of Action of Living, Apoptotic, and Dead MSCs.
    Weiss ARR; Dahlke MH
    Front Immunol; 2019; 10():1191. PubMed ID: 31214172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Priming Equine Bone Marrow-Derived Mesenchymal Stem Cells with Proinflammatory Cytokines: Implications in Immunomodulation-Immunogenicity Balance, Cell Viability, and Differentiation Potential.
    Barrachina L; Remacha AR; Romero A; Vázquez FJ; Albareda J; Prades M; Gosálvez J; Roy R; Zaragoza P; Martín-Burriel I; Rodellar C
    Stem Cells Dev; 2017 Jan; 26(1):15-24. PubMed ID: 27712399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.